A competitive sPLA2-IIA inhibitor with IC50 values of 80, 30, 120, 110, 520, >1600, and >1600 nM for sPLA2-hGIIA, -mGIIA, -rGIIA, -hGV, -mGV, -hGX, and -mGX, respectively; ameliorates local inflammatory responses in TPA-induced mouse ear edema at 45 µg/ear or 11 mg/kg i.v.